MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Oncothyreon Company Profile (NASDAQ:ONTY)

Consensus Ratings for Oncothyreon (NASDAQ:ONTY) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $4.50 (34.33% upside)

Analysts' Ratings History for Oncothyreon (NASDAQ:ONTY)
Show:
DateFirmActionRatingPrice TargetActions
8/10/2015Cantor FitzgeraldReiterated RatingHold$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015HC WainwrightBoost Price Target$4.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Cantor FitzgeraldReiterated RatingHold$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Jefferies GroupBoost Price TargetBuy$2.50 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015Jefferies GroupInitiated CoverageBuy$2.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015Cantor FitzgeraldReiterated RatingHold$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2014HC WainwrightInitiated CoverageBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2014WedbushInitiated CoverageBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014WedbushLower Price Target$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2014Cantor FitzgeraldDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2014Stifel NicolausBoost Price TargetBuy$3.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha